基于里程碑的增强重返赛场计划在年轻运动员前交叉韧带重建后成本效益优于标准时间标准
该研究采用经济与决策分析模型,从支付方视角比较前交叉韧带重建后增强重返赛场策略与标准康复的成本效益。增强策略增加神经肌肉再训练、高级测试和医生随访,保守估计额外花费969美元,并假设移植物再断裂风险降低25%。结果显示增强策略更具成本效益,只要额外成本低于2092美元或对侧ACL损伤减少超过13.8%即保持成本效益。
要点
- 增强重返赛场策略比标准康复更具成本效益。
- 增强策略额外成本低于2092美元时仍具成本效益。
- 对侧ACL损伤减少超过13.8%时增强策略具成本效益。
核心结论
- 增强重返赛场策略在年轻运动员ACL重建后相比标准康复具有成本效益。
- 即使仅假设移植物再断裂风险适度降低,增强策略仍具成本效益。
研究设计与样本
- 研究设计为经济与决策分析,使用决策分析模型比较标准康复与增强重返赛场策略。
- 成本效益从支付方视角评估,模型参数来自文献。
主要发现
- 增强重返赛场策略比标准康复更具成本效益。
- 单因素阈值分析显示,增强策略额外成本低于2092美元时仍具成本效益。
- 增强策略使对侧ACL损伤发生率降低超过13.8%时仍具成本效益。
关键数值与推荐
- 增量成本效益比阈值小于10万美元/质量调整生命年用于判定成本效益。
- 基础案例中增强策略比标准康复保守估计多花费969美元。
- 增强策略完成被认为相比标准康复 confer 25%的移植物再断裂风险降低。
临床怎么用
- 研究为支付方提供了增强重返赛场计划成本效益的证据,支持使用此类计划。
- 敏感性分析可用于判断任何给定重返赛场计划是否具有成本效益, regardless of 具体组成部分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Safe return to play (RTP) after anterior cruciate ligament (ACL) reconstruction is critical to patient satisfaction. Enhanced rehabilitation after ACL reconstruction with appropriate objective criteria for RTP may reduce the risk of subsequent injury. The cost-effectiveness of an enhanced RTP (eRTP) strategy relative to standard post-ACL reconstruction rehabilitation has not been investigated. PURPOSE: To determine if an eRTP strategy after ACL reconstruction is cost-effective compared with standard rehabilitation. STUDY DESIGN: Economic and decision analysis. METHODS: A decision-analysis model was utilized to compare standard rehabilitation with an eRTP strategy, which includes additional neuromuscular retraining, advanced testing, and follow-up physician visits. Cost-effectiveness was evaluated from a payer perspective. Costs of surgical procedures and rehabilitation protocols, risks of graft rupture and contralateral ACL injury, risk reductions as a result of the eRTP strategy, and relevant health utilities were derived from the literature. An incremental cost-effectiveness ratio of <$100,000/quality-adjusted life-year was used to determine cost-effectiveness. Sensitivity analyses were performed on pertinent model parameters to assess their effect on base case conclusions. In the base case analysis, the eRTP strategy cost was conservatively estimated to be $969 more than the standard rehabilitation protocol. Completion of the eRTP strategy was considered to confer a 25% risk reduction for graft rupture in comparison with standard rehabilitation. RESULTS: The eRTP strategy was more cost-effective than standard rehabilitation alone. Based on 1-way threshold analyses, the eRTP strategy was cost-effective as long as its additional cost over standard rehabilitation was <$2092 or the eRTP strategy decreased the incidence of contralateral ACL rupture by >13.8%. CONCLUSION: The eRTP strategy in this study adds additional neuromuscular retraining and additional physician follow-up-as well as advanced testing goals upon which RTP is contingent-to traditional physical therapy. Our data suggest that these additions are cost-effective, even assuming only modest associated decreases in ACL graft failure. This study also determined that the only variable that had the potential to change the cost-effectiveness conclusion based on predetermined ranges was the additional cost of rehabilitation based on 1-way sensitivity analysis. CLINICAL RELEVANCE: This study provides evidence of cost-effectiveness for payers, supporting the use of enhanced RTP programs. The sensitivity analyses herein may be used to determine if any given RTP program going forward is cost-effective, regardless of the exact components of the program.
引用
- DeFrancesco CJ, Lebrun DG, Molony JT, et al. Safer and Cheaper: An Enhanced Milestone-Based Return to Play Program After Anterior Cruciate Ligament Reconstruction in Young Athletes Is Cost-Effective Compared With Standard Time-Based Return to Play Criteria. Am J Sports Med. 2020. PMID: 32182102. doi:10.1177/0363546520907914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。